lobbying_activities: 2183915
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2183915 | 926d9721-2f7d-450e-baa2-0f16f0a11fd1 | Q3 | RED+BLUE STRATEGIES | 400693064 | COHERUS BIOSCIENCES | 2018 | third_quarter | PHA | Executive and Legislative initiatives to allow the biosimilars market place to succeed in the United States. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-10-15T08:52:44.727000-04:00 |